Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach

M Aliyu, FT Zohora, AU Anka, K Ali, S Maleknia… - International …, 2022 - Elsevier
Several studies have shown that interleukin 6 (IL-6) is a multifunctional cytokine with both
pro-inflammatory and anti-inflammatory activity, depending on the immune response …

Morphea: the 2023 update

C Papara, DA De Luca, K Bieber, A Vorobyev… - Frontiers in …, 2023 - frontiersin.org
Morphea, also known as localized scleroderma, is a chronic inflammatory connective tissue
disorder with variable clinical presentations, that affects both adults and children. It is …

Interleukin-6 and pulmonary hypertension: from physiopathology to therapy

WJ Xu, Q Wu, WN He, S Wang, YL Zhao… - Frontiers in …, 2023 - frontiersin.org
Pulmonary hypertension (PH) is a progressive, pulmonary vascular disease with high
morbidity and mortality. Unfortunately, the pathogenesis of PH is complex and remains …

The role of macrophages in connective tissue disease-associated interstitial lung disease: focusing on molecular mechanisms and potential treatment strategies

CC Tseng, YW Sung, KY Chen, PY Wang… - International Journal of …, 2023 - mdpi.com
Connective tissue disease-associated interstitial lung disease (CTD-ILD) is a severe
manifestation of CTD that leads to significant morbidity and mortality. Clinically, ILD can …

[HTML][HTML] Recent advances in strategies to target the behavior of macrophages in wound healing

H Zheng, X Cheng, L Jin, S Shan, J Yang… - Biomedicine & …, 2023 - Elsevier
Chronic wounds and scar formation are widespread due to limited suitable remedies. The
macrophage is a crucial regulator in wound healing, controlling the onset and termination of …

[HTML][HTML] Pharmacotherapies in dupuytren disease: current and novel strategies

AG Lambi, SN Popoff, P Benhaim, MF Barbe - The Journal of hand surgery, 2023 - Elsevier
Dupuytren disease is a benign, progressive fibroproliferative disorder of the hands. To date,
only one pharmacotherapy (clostridial collagenase) has been approved for use in …

cGAS deficiency enhances inflammasome activation in macrophages and inflammatory pathology in pristane-induced lupus

S Kumpunya, A Thim-Uam, C Thumarat… - Frontiers in …, 2022 - frontiersin.org
Introduction Type I interferon (IFN) plays a vital role in the pathogenesis of systemic lupus
erythematosus. Cyclic GMP AMP synthase (cGAS) is a cytosolic DNA sensor that recognizes …

Autoantibodies as biomarker and therapeutic target in systemic sclerosis

H Graßhoff, K Fourlakis, S Comdühr, G Riemekasten - Biomedicines, 2022 - mdpi.com
Systemic sclerosis (SSc) is a rare connective tissue disorder characterized by immune
dysregulation evoking the pathophysiological triad of inflammation, fibrosis and …

Trace Element Deficiency in Systemic Sclerosis—Too Much Effort for Some Traces?

D Opriș-Belinski, CO Cobilinschi, S Caraiola… - Nutrients, 2024 - mdpi.com
Trace elements are essential for several physiological processes. To date, various data
have suggested that inadequate levels of trace elements may be involved in the …

Oral submucous fibrosis: pathogenesis and therapeutic approaches

J Tang, J Liu, Z Zhou, X Cui, H Tu, J Jia… - International Journal of …, 2025 - nature.com
Oral submucous fibrosis (OSF), characterized by excessive deposition of extracellular matrix
(ECM) that causes oral mucosal tissue sclerosis, and even cancer transformation, is a …